BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Baxter International, Inc. (BAX) Halts Heparin Production Amid Reactions


2/12/2008 7:45:36 AM

CHICAGO -(Dow Jones)- Baxter International Inc. (BAX) has temporarily halted production of certain heparin vials amid reports of serious adverse reactions to the widely used, injectable blood thinner, including some deaths that may be related to the drug. The Deerfield, Ill., company has not broadened a prior recall of heparin, however, amid worries that such action would starve the market of a key tool that is used in a range of procedures, from dialysis to heart surgery. Heparin is a generic prescription drug, and Baxter is a major manufacturer that sells about 100,000 vials per day.

Read at CNN Money
Read at Reuters
Read at Medical News Today
Read at WebMD
Read at FDA

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES